Status:
COMPLETED
Treatment of Rheumatologic Patients With Sarcopenia
Lead Sponsor:
University of Bari
Conditions:
Rheumatic Diseases
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Sarcopenia is defined as a pathological condition related to muscle strength and muscle mass reduction. It is caused by ageing (primary sarcopenia) and diseases associated with systemic inflammation (...
Detailed Description
Sarcopenia is linked to two distinct pathogenetic mechanisms that often overlap: ageing (primary sarcopenia), and diseases associated with either systemic inflammation or impaired physical activity, o...
Eligibility Criteria
Inclusion
- Rheumatologic patients able to perform the handgrip test.
Exclusion
- Upper limb arthropathy, chronic kidney disease with an eGFR \<50 ml/min, severe congestive heart failure, cancer, decompensated diabetes, severe respiratory failure.
Key Trial Info
Start Date :
January 31 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT07135388
Start Date
January 31 2021
End Date
December 31 2024
Last Update
August 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Polyclinic University Hospital
Bari, BA, Italy, 70124